RU2010110036A - Производные пиперидина в качестве агонистов мускариновых рецепторов - Google Patents
Производные пиперидина в качестве агонистов мускариновых рецепторов Download PDFInfo
- Publication number
- RU2010110036A RU2010110036A RU2010110036/04A RU2010110036A RU2010110036A RU 2010110036 A RU2010110036 A RU 2010110036A RU 2010110036/04 A RU2010110036/04 A RU 2010110036/04A RU 2010110036 A RU2010110036 A RU 2010110036A RU 2010110036 A RU2010110036 A RU 2010110036A
- Authority
- RU
- Russia
- Prior art keywords
- alkyl
- alkoxy
- compound
- heterocycloalkyl
- piperidyl
- Prior art date
Links
- UQOFGTXDASPNLL-XHNCKOQMSA-N Muscarine Chemical compound C[C@@H]1O[C@H](C[N+](C)(C)C)C[C@H]1O UQOFGTXDASPNLL-XHNCKOQMSA-N 0.000 title 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical class C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 title 1
- 239000000018 receptor agonist Substances 0.000 title 1
- 229940044601 receptor agonist Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract 47
- 150000003839 salts Chemical class 0.000 claims abstract 21
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims abstract 18
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims abstract 18
- 150000002431 hydrogen Chemical group 0.000 claims abstract 13
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract 13
- 239000001257 hydrogen Substances 0.000 claims abstract 13
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims abstract 12
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims abstract 12
- -1 C1-7alkyl Chemical group 0.000 claims abstract 12
- 125000003320 C2-C6 alkenyloxy group Chemical group 0.000 claims abstract 12
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims abstract 12
- 239000000203 mixture Substances 0.000 claims abstract 10
- 229910052736 halogen Inorganic materials 0.000 claims abstract 7
- 150000002367 halogens Chemical class 0.000 claims abstract 7
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims abstract 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract 6
- 125000000217 alkyl group Chemical group 0.000 claims 74
- 125000003545 alkoxy group Chemical group 0.000 claims 50
- 125000005133 alkynyloxy group Chemical group 0.000 claims 10
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 10
- 238000000034 method Methods 0.000 claims 5
- 239000010802 sludge Substances 0.000 claims 4
- NXFFJDQHYLNEJK-UHFFFAOYSA-N 2-[4-[(4-chlorophenyl)methyl]-7-fluoro-5-methylsulfonyl-2,3-dihydro-1h-cyclopenta[b]indol-3-yl]acetic acid Chemical compound C1=2C(S(=O)(=O)C)=CC(F)=CC=2C=2CCC(CC(O)=O)C=2N1CC1=CC=C(Cl)C=C1 NXFFJDQHYLNEJK-UHFFFAOYSA-N 0.000 claims 2
- QZHXKFXCKFGNJH-NVPCEHRXSA-N but-2-ynyl 3-[4-[(3as,7as)-2-oxo-3a,4,5,6,7,7a-hexahydro-3h-benzimidazol-1-yl]piperidin-1-yl]-3-methylpyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OCC#CC)CCC1(C)N1CCC(N2C(N[C@H]3CCCC[C@@H]32)=O)CC1 QZHXKFXCKFGNJH-NVPCEHRXSA-N 0.000 claims 2
- ZXKUTOMRBVXFKV-OALUTQOASA-N propan-2-yl 4-[4-[(3as,7as)-2-oxo-3a,4,5,6,7,7a-hexahydro-3h-benzimidazol-1-yl]piperidin-1-yl]-4-methylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1(C)N1CCC(N2C(N[C@H]3CCCC[C@@H]32)=O)CC1 ZXKUTOMRBVXFKV-OALUTQOASA-N 0.000 claims 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 208000019901 Anxiety disease Diseases 0.000 claims 1
- 230000036506 anxiety Effects 0.000 claims 1
- XXXPJMMKHPCKGA-PMACEKPBSA-N but-2-ynyl 4-[4-[(3as,7as)-2-oxo-3a,4,5,6,7,7a-hexahydro-3h-benzimidazol-1-yl]piperidin-1-yl]-4-methylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OCC#CC)CCC1(C)N1CCC(N2C(N[C@H]3CCCC[C@@H]32)=O)CC1 XXXPJMMKHPCKGA-PMACEKPBSA-N 0.000 claims 1
- SSJXIUAHEKJCMH-UHFFFAOYSA-N cyclohexane-1,2-diamine Chemical compound NC1CCCCC1N SSJXIUAHEKJCMH-UHFFFAOYSA-N 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- LJENYWOZYGSALB-LGJCEAAXSA-N ethyl 3-[4-[(3ar,7ar)-2-oxo-3a,4,5,6,7,7a-hexahydro-3h-benzimidazol-1-yl]piperidin-1-yl]-3-methylpyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OCC)CCC1(C)N1CCC(N2C(N[C@@H]3CCCC[C@H]32)=O)CC1 LJENYWOZYGSALB-LGJCEAAXSA-N 0.000 claims 1
- FSRWEZFSESZVCX-NOORDXFBSA-N ethyl 3-[4-[(3as,7ar)-2-oxo-3a,4,5,6,7,7a-hexahydro-3h-indol-1-yl]piperidin-1-yl]-3-methylpyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OCC)CCC1(C)N1CCC(N2C(C[C@@H]3CCCC[C@H]32)=O)CC1 FSRWEZFSESZVCX-NOORDXFBSA-N 0.000 claims 1
- LJENYWOZYGSALB-NBJLRHFZSA-N ethyl 3-[4-[(3as,7as)-2-oxo-3a,4,5,6,7,7a-hexahydro-3h-benzimidazol-1-yl]piperidin-1-yl]-3-methylpyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OCC)CCC1(C)N1CCC(N2C(N[C@H]3CCCC[C@@H]32)=O)CC1 LJENYWOZYGSALB-NBJLRHFZSA-N 0.000 claims 1
- IVJDEIANCSDDAO-QZTJIDSGSA-N ethyl 4-[4-[(3ar,7ar)-2-oxo-3a,4,5,6,7,7a-hexahydro-3h-benzimidazol-1-yl]piperidin-1-yl]-4-methylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OCC)CCC1(C)N1CCC(N2C(N[C@@H]3CCCC[C@H]32)=O)CC1 IVJDEIANCSDDAO-QZTJIDSGSA-N 0.000 claims 1
- IVJDEIANCSDDAO-MSOLQXFVSA-N ethyl 4-[4-[(3ar,7as)-2-oxo-3a,4,5,6,7,7a-hexahydro-3h-benzimidazol-1-yl]piperidin-1-yl]-4-methylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OCC)CCC1(C)N1CCC(N2C(N[C@@H]3CCCC[C@@H]32)=O)CC1 IVJDEIANCSDDAO-MSOLQXFVSA-N 0.000 claims 1
- FBMWQXFLRCKPIQ-OALUTQOASA-N ethyl 4-[4-[(3as,7as)-2-oxo-3a,4,5,6,7,7a-hexahydro-3h-benzimidazol-1-yl]piperidin-1-yl]-4-ethylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OCC)CCC1(CC)N1CCC(N2C(N[C@H]3CCCC[C@@H]32)=O)CC1 FBMWQXFLRCKPIQ-OALUTQOASA-N 0.000 claims 1
- IVJDEIANCSDDAO-ROUUACIJSA-N ethyl 4-[4-[(3as,7as)-2-oxo-3a,4,5,6,7,7a-hexahydro-3h-benzimidazol-1-yl]piperidin-1-yl]-4-methylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OCC)CCC1(C)N1CCC(N2C(N[C@H]3CCCC[C@@H]32)=O)CC1 IVJDEIANCSDDAO-ROUUACIJSA-N 0.000 claims 1
- ICCQIQRJEGGHIA-PMACEKPBSA-N ethyl 4-[4-[(3as,7as)-2-oxo-3a,4,5,6,7,7a-hexahydro-3h-benzimidazol-1-yl]piperidin-1-yl]-4-propylpiperidine-1-carboxylate Chemical compound C1CC(N2C(N[C@H]3CCCC[C@@H]32)=O)CCN1C1(CCC)CCN(C(=O)OCC)CC1 ICCQIQRJEGGHIA-PMACEKPBSA-N 0.000 claims 1
- DYRVQYFEYGVZSQ-NRAVZPKASA-N methyl 3-[4-[(3as,7as)-2-oxo-3a,4,5,6,7,7a-hexahydro-3h-benzimidazol-1-yl]piperidin-1-yl]-3-methylpyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC)CCC1(C)N1CCC(N2C(N[C@H]3CCCC[C@@H]32)=O)CC1 DYRVQYFEYGVZSQ-NRAVZPKASA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- AQNYLONDPBAVGN-GAOSQQNJSA-N prop-2-ynyl 3-[4-[(3as,7as)-2-oxo-3a,4,5,6,7,7a-hexahydro-3h-benzimidazol-1-yl]piperidin-1-yl]-3-methylpyrrolidine-1-carboxylate Chemical compound C1CC(N2C(N[C@H]3CCCC[C@@H]32)=O)CCN1C1(C)CCN(C(=O)OCC#C)C1 AQNYLONDPBAVGN-GAOSQQNJSA-N 0.000 claims 1
- PTNFPCNYGTUQIT-OALUTQOASA-N prop-2-ynyl 4-[4-[(3as,7as)-2-oxo-3a,4,5,6,7,7a-hexahydro-3h-benzimidazol-1-yl]piperidin-1-yl]-4-methylpiperidine-1-carboxylate Chemical compound C1CC(N2C(N[C@H]3CCCC[C@@H]32)=O)CCN1C1(C)CCN(C(=O)OCC#C)CC1 PTNFPCNYGTUQIT-OALUTQOASA-N 0.000 claims 1
- ZXKUTOMRBVXFKV-RTBURBONSA-N propan-2-yl 4-[4-[(3ar,7ar)-2-oxo-3a,4,5,6,7,7a-hexahydro-3h-benzimidazol-1-yl]piperidin-1-yl]-4-methylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1(C)N1CCC(N2C(N[C@@H]3CCCC[C@H]32)=O)CC1 ZXKUTOMRBVXFKV-RTBURBONSA-N 0.000 claims 1
- IXBYUAVOBQEXJC-QUCCMNQESA-N propan-2-yl 4-[4-[(3ar,7as)-2-oxo-3a,4,5,6,7,7a-hexahydro-3h-indol-1-yl]piperidin-1-yl]-4-methylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1(C)N1CCC(N2C(C[C@H]3CCCC[C@@H]32)=O)CC1 IXBYUAVOBQEXJC-QUCCMNQESA-N 0.000 claims 1
- ZILONDDNNQKVBD-PMACEKPBSA-N propan-2-yl 4-[4-[(3as,7as)-2-oxo-3a,4,5,6,7,7a-hexahydro-3h-benzimidazol-1-yl]piperidin-1-yl]-4-ethylpiperidine-1-carboxylate Chemical compound C1CC(N2C(N[C@H]3CCCC[C@@H]32)=O)CCN1C1(CC)CCN(C(=O)OC(C)C)CC1 ZILONDDNNQKVBD-PMACEKPBSA-N 0.000 claims 1
- XDVGHJKTMFQYAT-SFTDATJTSA-N propan-2-yl 4-[4-[(3as,7as)-2-oxo-3a,4,5,6,7,7a-hexahydro-3h-benzimidazol-1-yl]piperidin-1-yl]-4-propylpiperidine-1-carboxylate Chemical compound C1CC(N2C(N[C@H]3CCCC[C@@H]32)=O)CCN1C1(CCC)CCN(C(=O)OC(C)C)CC1 XDVGHJKTMFQYAT-SFTDATJTSA-N 0.000 claims 1
- 201000000980 schizophrenia Diseases 0.000 claims 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 4
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97128807P | 2007-09-11 | 2007-09-11 | |
| US60/971,288 | 2007-09-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2010110036A true RU2010110036A (ru) | 2011-10-20 |
Family
ID=40011174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2010110036/04A RU2010110036A (ru) | 2007-09-11 | 2008-09-09 | Производные пиперидина в качестве агонистов мускариновых рецепторов |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8119661B2 (https=) |
| EP (1) | EP2197843B1 (https=) |
| JP (1) | JP2010539151A (https=) |
| KR (1) | KR20100052528A (https=) |
| CN (1) | CN101874020B (https=) |
| AR (1) | AR071245A1 (https=) |
| AT (1) | ATE539056T1 (https=) |
| AU (1) | AU2008299604A1 (https=) |
| BR (1) | BRPI0816331A2 (https=) |
| CA (1) | CA2699286A1 (https=) |
| CL (1) | CL2008002689A1 (https=) |
| ES (1) | ES2377772T3 (https=) |
| MX (1) | MX2010002584A (https=) |
| PE (1) | PE20091090A1 (https=) |
| RU (1) | RU2010110036A (https=) |
| TW (1) | TW200924766A (https=) |
| UY (1) | UY31334A1 (https=) |
| WO (1) | WO2009034380A1 (https=) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2685230C2 (ru) * | 2014-02-06 | 2019-04-17 | Хептарес Терапьютикс Лимитед | Бициклические азотсодержащие соединения как агонисты М1 мускариновых рецепторов |
| RU2811601C1 (ru) * | 2014-02-06 | 2024-01-15 | Хептарес Терапьютикс Лимитед | Бициклические азотсодержащие соединения как агонисты М1 мускариновых рецепторов |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200815405A (en) * | 2006-06-09 | 2008-04-01 | Astrazeneca Ab | Novel compounds |
| TW200813018A (en) * | 2006-06-09 | 2008-03-16 | Astrazeneca Ab | Novel compounds |
| US20090221642A1 (en) * | 2008-03-03 | 2009-09-03 | Astrazeneca Ab | Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof-176 |
| US20090275574A1 (en) * | 2008-05-05 | 2009-11-05 | Astrazeneca Ab | Novel compounds-300 |
| AU2012338581B2 (en) | 2011-11-18 | 2016-12-08 | Nxera Pharma Uk Limited | Muscarinic M1 receptor agonists |
| BR112015006029B1 (pt) | 2012-09-18 | 2022-01-25 | Heptares Therapeutics Limited | Compostos aza bicíclicos como agonistas de receptor m1 muscarínicos, composição farmacêutica compreendendo ditos compostos e uso dos mesmos para tratar um distúrbio cognitivo ou distúrbio psicótico ou para tratar ou reduzir a gravidade de dores agudas, crônicas, neuropáticas ou inflamatórias |
| WO2014122474A1 (en) | 2013-02-07 | 2014-08-14 | Takeda Pharmaceutical Company Limited | Piperidin-1 -yl and azepin-1 -yl carboxylates as muscarinic m4 receptor agonists |
| GB2519470A (en) * | 2013-09-18 | 2015-04-22 | Heptares Therapeutics Ltd | Bicyclic aza compounds as muscarinic M1 receptor agonists |
| GB201404922D0 (en) | 2014-03-19 | 2014-04-30 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201513743D0 (en) | 2015-08-03 | 2015-09-16 | Heptares Therapeutics Ltd | Muscarinic agonists |
| GB201519352D0 (en) | 2015-11-02 | 2015-12-16 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201617454D0 (en) | 2016-10-14 | 2016-11-30 | Heptares Therapeutics Limited | Pharmaceutical compounds |
| GB201810239D0 (en) | 2018-06-22 | 2018-08-08 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201819960D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201819961D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB202020191D0 (en) | 2020-12-18 | 2021-02-03 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3066434D1 (en) | 1979-11-21 | 1984-03-08 | Kyowa Hakko Kogyo Kk | Novel piperidine derivatives, method for the preparation thereof and pharmaceutical compositions containing them |
| DE4302051A1 (de) | 1993-01-26 | 1994-07-28 | Thomae Gmbh Dr K | 5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| ATE216580T1 (de) | 1993-07-16 | 2002-05-15 | Merck & Co Inc | Benzoxazinon- und benzopyrimidinon- piperidinyl- verbindungen als tokolytische oxytocin-rezeptor- antagonisten |
| JP2002515008A (ja) | 1994-10-27 | 2002-05-21 | メルク エンド カンパニー インコーポレーテッド | ムスカリン・アンタゴニスト |
| US5756508A (en) | 1995-10-31 | 1998-05-26 | Merck & Co., Inc. | Muscarine antagonists |
| WO1997016192A1 (en) | 1995-10-31 | 1997-05-09 | Merck & Co., Inc. | Muscarine antagonists |
| US5756497A (en) | 1996-03-01 | 1998-05-26 | Merck & Co., Inc. | Tocolytic oxytocin receptor antagonists |
| DE59711622D1 (de) | 1996-09-10 | 2004-06-17 | Boehringer Ingelheim Pharma | Abgewandelte aminosäuren, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| JPH10158192A (ja) | 1996-10-03 | 1998-06-16 | Eisai Co Ltd | 移植片対宿主疾患（ｇｖｈｄ）の治療および臓器移植時の移植片拒絶反応抑制のための医薬組成物 |
| SE9704546D0 (sv) | 1997-12-05 | 1997-12-05 | Astra Pharma Prod | Novel compounds |
| AU2307999A (en) | 1997-12-23 | 1999-07-12 | Alcon Laboratories, Inc. | Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions |
| EA200000683A1 (ru) | 1998-01-19 | 2000-12-25 | Пфайзер Инк. | Производные ряда 4-(2-кето-1-бензимидазолинил)пиперидина в качестве агонистов orl1-рецептора |
| MA26659A1 (fr) | 1998-08-06 | 2004-12-20 | Pfizer | Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation. |
| JP2000323278A (ja) | 1999-05-14 | 2000-11-24 | Toray Ind Inc | 発光素子 |
| ATE275141T1 (de) | 1999-10-13 | 2004-09-15 | Banyu Pharma Co Ltd | Substituierte imidazolin-derivate |
| SE9904652D0 (sv) | 1999-12-17 | 1999-12-17 | Astra Pharma Prod | Novel Compounds |
| EP1309593B1 (en) | 2000-08-14 | 2006-03-15 | Ortho-McNeil Pharmaceutical, Inc. | Substituted pyrazoles |
| JP2002302675A (ja) | 2001-04-06 | 2002-10-18 | Fuji Photo Film Co Ltd | 液晶組成物、それを用いた液晶素子およびアゾ化合物 |
| US6872733B2 (en) * | 2001-04-18 | 2005-03-29 | Euro-Celtique S.A. | Benzimidazolone compounds |
| NZ551453A (en) | 2001-04-18 | 2008-02-29 | Euro Celtique Sa | Nociceptin analogs for the treatment of pain |
| JPWO2002085890A1 (ja) | 2001-04-20 | 2004-08-12 | 萬有製薬株式会社 | ベンズイミダゾロン誘導体 |
| AR036366A1 (es) * | 2001-08-29 | 2004-09-01 | Schering Corp | Derivados de piperidina utiles como antagonistas de ccr5, composiciones farmaceuticas, el uso de dichos derivados para la fabricación de un medicamento y un kit |
| WO2004089942A2 (en) | 2001-10-02 | 2004-10-21 | Acadia Pharmaceuticals Inc. | Benzimidazolidinone derivatives as muscarinic agents |
| WO2003037890A2 (en) | 2001-11-01 | 2003-05-08 | Icagen, Inc. | Piperidines |
| PT1499316E (pt) | 2002-04-18 | 2008-06-30 | Schering Corp | Derivados de (1-4-piperidinil)benzimidazole úteis como antagonistas de histamina h3 |
| JP2005532361A (ja) | 2002-06-17 | 2005-10-27 | メルク エンド カムパニー インコーポレーテッド | 高眼圧症の治療用の眼科用組成物 |
| WO2004069828A1 (ja) | 2003-02-04 | 2004-08-19 | Mitsubishi Pharma Corporation | ピペリジン化合物およびその医薬用途 |
| CA2524221A1 (en) | 2003-04-30 | 2004-11-18 | The Institutes For Pharmaceutical Discovery, Llc | Substituted heteroaryls as inhibitors of protein tyrosine phosphatases |
| CN1898231B (zh) | 2003-11-03 | 2010-10-27 | 先灵公司 | 用作趋化因子受体抑制剂的双六氢吡啶衍生物 |
| US20050250794A1 (en) | 2003-12-19 | 2005-11-10 | Andrew Napper | Methods of treating a disorder |
| US20050228023A1 (en) | 2003-12-19 | 2005-10-13 | Sri International | Agonist and antagonist ligands of the nociceptin receptor |
| AU2005249494A1 (en) | 2004-05-28 | 2005-12-15 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| EP1790637B1 (en) | 2004-09-13 | 2014-01-29 | Ono Pharmaceutical Co., Ltd. | Derivatives of N-4-piperidyl urea and medicaments containing them as active ingredient |
| CA2581930A1 (en) | 2004-09-27 | 2006-04-06 | Jane Trepel | Modulating mxa expression |
| WO2006038594A1 (ja) | 2004-10-04 | 2006-04-13 | Ono Pharmaceutical Co., Ltd. | Ｎ型カルシウムチャネル阻害薬 |
| WO2006130469A1 (en) | 2005-05-27 | 2006-12-07 | Oregon Health & Science University | Stimulation of neurite outgrowth by small molecules |
| WO2007036711A1 (en) | 2005-09-30 | 2007-04-05 | Glaxo Group Limited | BENZIMIDAZOLONES WHICH HAVE ACTIVITY AT Ml RECEPTOR |
| TW200813018A (en) * | 2006-06-09 | 2008-03-16 | Astrazeneca Ab | Novel compounds |
-
2008
- 2008-09-08 US US12/205,968 patent/US8119661B2/en not_active Expired - Fee Related
- 2008-09-09 MX MX2010002584A patent/MX2010002584A/es not_active Application Discontinuation
- 2008-09-09 CA CA2699286A patent/CA2699286A1/en not_active Abandoned
- 2008-09-09 KR KR1020107005282A patent/KR20100052528A/ko not_active Withdrawn
- 2008-09-09 AT AT08806636T patent/ATE539056T1/de active
- 2008-09-09 WO PCT/GB2008/050802 patent/WO2009034380A1/en not_active Ceased
- 2008-09-09 BR BRPI0816331 patent/BRPI0816331A2/pt not_active Application Discontinuation
- 2008-09-09 CN CN2008801155657A patent/CN101874020B/zh not_active Expired - Fee Related
- 2008-09-09 TW TW097134582A patent/TW200924766A/zh unknown
- 2008-09-09 RU RU2010110036/04A patent/RU2010110036A/ru unknown
- 2008-09-09 JP JP2010524582A patent/JP2010539151A/ja active Pending
- 2008-09-09 EP EP08806636A patent/EP2197843B1/en not_active Not-in-force
- 2008-09-09 AU AU2008299604A patent/AU2008299604A1/en not_active Abandoned
- 2008-09-09 ES ES08806636T patent/ES2377772T3/es active Active
- 2008-09-10 AR ARP080103926A patent/AR071245A1/es unknown
- 2008-09-10 CL CL2008002689A patent/CL2008002689A1/es unknown
- 2008-09-10 UY UY31334A patent/UY31334A1/es unknown
- 2008-09-11 PE PE2008001586A patent/PE20091090A1/es not_active Application Discontinuation
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2685230C2 (ru) * | 2014-02-06 | 2019-04-17 | Хептарес Терапьютикс Лимитед | Бициклические азотсодержащие соединения как агонисты М1 мускариновых рецепторов |
| RU2811601C1 (ru) * | 2014-02-06 | 2024-01-15 | Хептарес Терапьютикс Лимитед | Бициклические азотсодержащие соединения как агонисты М1 мускариновых рецепторов |
| RU2811601C9 (ru) * | 2014-02-06 | 2024-03-26 | Хептарес Терапьютикс Лимитед | Бициклические азотсодержащие соединения как агонисты М1 мускариновых рецепторов |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2197843A1 (en) | 2010-06-23 |
| US8119661B2 (en) | 2012-02-21 |
| PE20091090A1 (es) | 2009-08-27 |
| BRPI0816331A2 (pt) | 2015-04-14 |
| EP2197843B1 (en) | 2011-12-28 |
| ATE539056T1 (de) | 2012-01-15 |
| ES2377772T3 (es) | 2012-03-30 |
| KR20100052528A (ko) | 2010-05-19 |
| AR071245A1 (es) | 2010-06-09 |
| UY31334A1 (es) | 2009-04-30 |
| CN101874020A (zh) | 2010-10-27 |
| CL2008002689A1 (es) | 2009-11-27 |
| AU2008299604A1 (en) | 2009-03-19 |
| US20090076078A1 (en) | 2009-03-19 |
| JP2010539151A (ja) | 2010-12-16 |
| TW200924766A (en) | 2009-06-16 |
| MX2010002584A (es) | 2010-03-26 |
| CN101874020B (zh) | 2012-11-07 |
| WO2009034380A1 (en) | 2009-03-19 |
| CA2699286A1 (en) | 2009-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2010110036A (ru) | Производные пиперидина в качестве агонистов мускариновых рецепторов | |
| JP2010539151A5 (https=) | ||
| RU2010135253A (ru) | Агонисты мускариновых рецепторов, композиции и способы лечения с их применением и способы их получения 177 | |
| RU2004104625A (ru) | Аналоги простагландинов в качестве агонистов рецептора ep4 | |
| RU2008145220A (ru) | Производные диазепана в качестве модуляторов хемокиновых рецепторов | |
| PE20091095A1 (es) | Moduladores de gamma secretasa | |
| RU2005132616A (ru) | Производные 2-фенокси и 2-фенилсульфонамида с ссr3 антагонистической активностью для лечения астмы и других воспалительных или иммунологических заболеваний | |
| PE20120031A1 (es) | Compuestos aril metil benzoquinazolinona como moduladores alostericos positivos del receptor m1 | |
| RU2008147542A (ru) | Агонисты мускариновых рецепторов, эффективные при лечении боли, болезни альцгеймера и шизофрении | |
| PE20081228A1 (es) | Compuesto heteromonociclico | |
| RU2005111225A (ru) | Производные триазаспиро[5.5]ундекана и лекарственные средства, содержащие их в качестве активного ингредиента | |
| RU2005102004A (ru) | Замещенные хинолины как антагонисты рецептора ccr5 | |
| RU2014105624A (ru) | Соединения индазола, способ их применения и фармацевтическая композиция | |
| RU2012145237A (ru) | Производные арилэтинила | |
| RU2014124101A (ru) | Использование тиено- и фуро- пиримидинов и пиримидинов в качестве ингибиторов калиевых каналов | |
| RU2007137649A (ru) | 2-(4-оксо-4н-хиназолин-3-ил)ацетамиды и их использование в качестве вазопрессин v3 антагонистов | |
| RU2015106787A (ru) | Замещенные пирролы, активные в качестве ингибиторов киназ | |
| RU2009120229A (ru) | Производные хинуклидинола в качестве антагонистов мускариновых рецепторов | |
| RU2006124518A (ru) | Ингибиторы фосфодиэстеразы 4, включая аналоги n-замещенного диариламина | |
| AR060658A1 (es) | Derivados de diceto-piperazina y piperidina como agentes antivirales | |
| PE20091444A1 (es) | Derivados de isoxazolo-pirazina | |
| RU2007120454A (ru) | Производные хинуклидина и их применение в качестве антагонистов мускариновых рецепторов м3 | |
| RU2012120307A (ru) | Позитивные аллостерические модуляторы (рам) | |
| RU2010136721A (ru) | Агонисты мускариновых рецепторов, композиции, способы лечения ими и способы их изготовления | |
| PE20091330A1 (es) | Derivados de 4-aminopirimidina como antagonistas de receptores de histamina h4 |